HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Nerve Stimulator Programmed by Handheld Computer

By HospiMedica staff writers
Posted on 02 Oct 2000
Print article
A vagus nerve stimulator for epileptic patients is being modified to allow programming by a handheld computer utilizing the Windows operating system. This will allow greater flexibility in programming, improve data automation, increase the comfort levels of both patient and doctor, and reduce costs, says developer Cyberonics, Inc. (Houston, TX, USA).

Cyberonics is focusing on several key areas for improvement of the device, including utilization of common industry programming standards, commercial off-the-shelf technology from multiple hardware vendors, and flash-card technology for easy data access and distribution. Called the NeuroCybernetic Prosthesis (NCP) System, the implanted stimulator is being studied as a potential treatment for severe depression, obesity, and Alzheimer's disease, in addition to epilepsy.

We also have plans for development of the programming system based on radio frequency (RF) technology, enabling distance programming of our devices, noted Richard P. Kuntz, vice president of operations at Cyberonics. This technology should eliminate any physical contact of the programming system with the patient and ultimately decrease patient apprehension.



Related Links:
Cyberonics, Inc
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Suction Electrode System
Strässle
New
Patient Monitor
Vista 300

Print article

Channels

Critical Care

view channel
Image: The Atmo Gas Capsule measures gases as it travels through the GI tract and transmits the data wirelessly (Photo courtesy of Atmo Biosciences)

Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market

Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more